Mandeep Kumar Arora

1.2k total citations
40 papers, 894 citations indexed

About

Mandeep Kumar Arora is a scholar working on Molecular Biology, Complementary and alternative medicine and Infectious Diseases. According to data from OpenAlex, Mandeep Kumar Arora has authored 40 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Complementary and alternative medicine and 5 papers in Infectious Diseases. Recurrent topics in Mandeep Kumar Arora's work include SARS-CoV-2 and COVID-19 Research (4 papers), Advanced Glycation End Products research (4 papers) and COVID-19 Clinical Research Studies (3 papers). Mandeep Kumar Arora is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), Advanced Glycation End Products research (4 papers) and COVID-19 Clinical Research Studies (3 papers). Mandeep Kumar Arora collaborates with scholars based in India, Saudi Arabia and United States. Mandeep Kumar Arora's co-authors include Umesh Kumar Singh, Pitchai Balakumar, Ashok Jangra, Krishna N. Reddy, Mohd Imran, Madhu B. Anand‐Srivastava, Manjeet Singh, Ritu Tomar, Syed Mohammed Basheeruddin Asdaq and Manjeet Singh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecules and Pharmacology & Therapeutics.

In The Last Decade

Mandeep Kumar Arora

35 papers receiving 869 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mandeep Kumar Arora India	14	307	173	147	117	102	40	894
De Jin China	15	347 1.1×	113 0.7×	100 0.7×	63 0.5×	63 0.6×	52	835
Tawar Qaradakhi Australia	15	356 1.2×	87 0.5×	93 0.6×	130 1.1×	50 0.5×	23	1.1k
Hongbo Weng China	18	335 1.1×	102 0.6×	50 0.3×	30 0.3×	132 1.3×	30	838
Jingbin Li China	18	518 1.7×	123 0.7×	51 0.3×	27 0.2×	138 1.4×	35	1.1k
Zheng Xu China	18	488 1.6×	85 0.5×	114 0.8×	23 0.2×	141 1.4×	35	1.1k
Nermin Abdel Hamid Sadik Egypt	21	421 1.4×	65 0.4×	39 0.3×	34 0.3×	218 2.1×	53	1.2k
Alaa Shafie Saudi Arabia	17	373 1.2×	98 0.6×	17 0.1×	79 0.7×	64 0.6×	94	920
Xiaoou Shan China	17	304 1.0×	65 0.4×	63 0.4×	27 0.2×	101 1.0×	61	874
Zhilei Wang China	19	654 2.1×	54 0.3×	171 1.2×	48 0.4×	186 1.8×	43	1.1k

Countries citing papers authored by Mandeep Kumar Arora

Since Specialization

Citations

This map shows the geographic impact of Mandeep Kumar Arora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mandeep Kumar Arora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mandeep Kumar Arora more than expected).

Fields of papers citing papers by Mandeep Kumar Arora

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mandeep Kumar Arora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mandeep Kumar Arora. The network helps show where Mandeep Kumar Arora may publish in the future.

Co-authorship network of co-authors of Mandeep Kumar Arora

This figure shows the co-authorship network connecting the top 25 collaborators of Mandeep Kumar Arora. A scholar is included among the top collaborators of Mandeep Kumar Arora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mandeep Kumar Arora. Mandeep Kumar Arora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rabbani, Syed Arman, et al.. (2024). Gastrointestinal adverse events associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the EudraVigilance and VigiAccess databases. Expert Opinion on Drug Safety. 25(1). 103–113. 4 indexed citations

Rabbani, Syed Arman, Mohamed El‐Tanani, Mandeep Kumar Arora, et al.. (2024). Safety profile of tirzepatide: A real-world pharmacovigilance analysis of EudraVigilance database. Clinical Epidemiology and Global Health. 30. 101805–101805. 5 indexed citations

Kalaiselvan, Vivekanandan, et al.. (2024). Neuronal toxicity of monoclonal antibodies (mAbs): an analysis of post-marketing reports from FDA Adverse Event Reporting System (FAERS) safety database. European Journal of Clinical Pharmacology. 80(11). 1685–1695. 1 indexed citations

Arora, Mandeep Kumar, et al.. (2024). Assessment of Neurologic Safety Profile of Immune Checkpoint Inhibitors:Evaluation of Adverse Drug Reaction Reports. Current Drug Safety. 19(3). 382–394. 2 indexed citations

Nair, Lakshmi S., Dinesh Kumar, Mandeep Kumar Arora, et al.. (2023). Hypoxia induced lactate acidosis modulates tumor microenvironment and lipid reprogramming to sustain the cancer cell survival. Frontiers in Oncology. 13. 1034205–1034205. 36 indexed citations

Imran, Mohd, Mohammed Kanan Alshammari, Mandeep Kumar Arora, et al.. (2023). Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects. Biomedicines. 11(2). 278–278. 19 indexed citations

Das, Sabya Sachi, Mandeep Kumar Arora, Janne Ruokolainen, et al.. (2023). Natural cationic polymer-derived injectable hydrogels for targeted chemotherapy. Materials Advances. 4(23). 6064–6091. 12 indexed citations

Arora, Mandeep Kumar, et al.. (2023). Cardiac safety profile of type II kinase inhibitors: Analysis of post-marketing reports from databases of European Medicine Agency & World Health Organization. DARU Journal of Pharmaceutical Sciences. 31(2). 107–118. 5 indexed citations

Imran, Mohd, Mandeep Kumar Arora, Anurag Chaudhary, et al.. (2022). MmpL3 Inhibition as a Promising Approach to Develop Novel Therapies against Tuberculosis: A Spotlight on SQ109, Clinical Studies, and Patents Literature. Biomedicines. 10(11). 2793–2793. 20 indexed citations

10.

Sharma, Satish Kumar, Syed Mohammed Basheeruddin Asdaq, Mohammed Kanan Alshammari, et al.. (2022). Combined therapy with ivermectin and doxycycline can effectively alleviate the cytokine storm of COVID-19 infection amid vaccination drive: A narrative review. Journal of Infection and Public Health. 15(5). 566–572. 4 indexed citations

11.

Imran, Mohd, et al.. (2022). Insight into the biological impact of COVID-19 and its vaccines on human health. Saudi Journal of Biological Sciences. 29(5). 3326–3337. 9 indexed citations

12.

Rai, Uddipak, Dhirodatta Senapati, & Mandeep Kumar Arora. (2022). Insights on the role of anti-inflammatory and immunosuppressive agents in the amelioration of diabetes. Diabetology International. 14(2). 134–144. 4 indexed citations

13.

Jangra, Ashok, et al.. (2021). Neuroprotective and acetylcholinesterase inhibitory activity of plumbagin in ICV-LPS induced behavioral deficits in rats. SHILAP Revista de lepidopterología. 2. 100060–100060. 13 indexed citations

14.

Imran, Mohd, Mandeep Kumar Arora, Syed Mohammed Basheeruddin Asdaq, et al.. (2021). Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19. Molecules. 26(19). 5795–5795. 137 indexed citations

15.

Arora, Mandeep Kumar, Parul Grover, Syed Mohammed Basheeruddin Asdaq, et al.. (2021). Potential role of nicotinamide analogues against SARS-COV-2 target proteins. Saudi Journal of Biological Sciences. 28(12). 7567–7574. 4 indexed citations

16.

Jangra, Ashok, et al.. (2020). Mangiferin ameliorates intracerebroventricular-quinolinic acid-induced cognitive deficits, oxidative stress, and neuroinflammation in Wistar rats. Indian Journal of Pharmacology. 52(4). 296–296. 13 indexed citations

17.

Arora, Mandeep Kumar & Umesh Kumar Singh. (2014). Oxidative Stress: Meeting Multiple Targets in Pathogenesis of Diabetic Nephropathy. Current Drug Targets. 15(5). 531–538. 68 indexed citations

18.

Arora, Mandeep Kumar & Umesh Kumar Singh. (2013). Molecular mechanisms in the pathogenesis of diabetic nephropathy: An update. Vascular Pharmacology. 58(4). 259–271. 191 indexed citations

19.

Balakumar, Pitchai, Mandeep Kumar Arora, & Manjeet Singh. (2009). Emerging role of PPAR ligands in the management of diabetic nephropathy. Pharmacological Research. 60(3). 170–173. 41 indexed citations

20.

Balakumar, Pitchai, et al.. (2009). Pathophysiology of Diabetic Nephropathy: Involvement of Multifaceted Signalling Mechanism. Journal of Cardiovascular Pharmacology. 54(2). 129–138. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact